Glial cell line-derived neurotrophic factor (GDNF), a neuronal survival factor, binds its co-receptor GDNF family receptor ␣1 (GFR␣1) in a 2:2 ratio and signals through the receptor tyrosine kinase RET. We have solved the GDNF 2 ⅐GFR␣1 2 complex structure at 2.35 Å resolution in the presence of a heparin mimic, sucrose octasulfate. The structure of our GDNF 2 ⅐GFR␣1 2 complex and the previously published artemin 2 ⅐GFR␣3 2 complex are unlike in three ways. First, we have experimentally identified residues that differ in the ligand-GFR␣ interface between the two structures, in particular ones that buttress the key conserved Arg GFR␣ -Glu ligand -Arg GFR␣ interaction. Second, the flexible GDNF ligand "finger" loops fit differently into the GFR␣s, which are rigid. Third, and we believe most importantly, the quaternary structure of the two tetramers is dissimilar, because the angle between the two GDNF monomers is different. This suggests that the RET-RET interaction differs in different ligand 2 -co-receptor 2 -RET 2 heterohexamer complexes. Consistent with this, we showed that GDNF 2 ⅐GFR␣1 2 and artemin 2 ⅐GFR␣3 2 signal differently in a mitogen-activated protein kinase assay. Furthermore, we have shown by mutagenesis and enzyme-linked immunosorbent assays of RET phosphorylation that RET probably interacts with GFR␣1 residues Arg-190, Lys-194, Arg-197, Gln-198, Lys-202, Arg-257, Arg-259, Glu-323, and Asp-324 upon both domains 2 and 3. Interestingly, in our structure, sucrose octasulfate also binds to the Arg 190 -Lys 202 region in GFR␣1 domain 2. This may explain how GDNF⅐GFR␣1 can mediate cell adhesion and how heparin might inhibit GDNF signaling through RET.
GDNF, 3 originally characterized as a growth factor promoting the survival of midbrain dopaminergic neurons (1), regulates the differentiation and development of many peripheral neurons (2) and is neuroprotective (3) . GDNF is also a morphogenic factor in kidney and spermatogonia development (reviewed by Airaksinen and Saarma (2)). Some clinical trials have indicated that perfusing GDNF into the putamen may be therapeutically beneficial in Parkinson disease (4) . These neuroprotective and therapeutic roles have generated wide interest in the study of the GDNF signaling system.
There are three other GDNF family ligands (GFLs), neurturin (NRTN (5)), artemin (ARTN (6)), and persephin (PSPN (7)), and knock-out mice experiments have made it clear that the order of biological importance is GDNF Ͼ Ͼ NRTN Ͼ ARTN Ͼ PSPN (2) . They all signal primarily through the receptor tyrosine kinase RET (8) . The extracellular region of RET has four cadherin-like domains and a cysteine-rich domain. Mutations in RET can cause both gain-of-function and loss-of-function diseases. In the former category are hereditary medullary thyroid carcinoma and multiple endocrine neoplasias of types 2A and 2B (9, 10) , whereas Hirschsprung disease is an example of the latter (10) .
GFLs are distant relatives of transforming growth factor ␤ (2). Each GFL has its own co-receptor ␣: GDNF requires GFR␣1; NRTN requires GFR␣2; ARTN requires GFR␣3; and PSPN requires GFR␣4 (2) . The GFR␣s, which are glycosylphosphatidylinositol-anchored to the cell surface, typically have three homologous cysteine-rich domains with C-terminal extensions of various lengths (11, 12) . Domain 2 (D2) clearly binds the GFL (13) (14) (15) . The roles of domain 1 (D1) and domain 3 (D3) are less certain, but D1 is not necessary for RET binding GFR␣1 (16) and is absent in GFR␣4 (11) . Many models have been proposed for the RET activation mechanism because of the requirement for a RET 2 ⅐GFR␣ 2 ⅐GFL 2 heterohexamer. The ARTN 2 ⅐GFR␣3 2 (13) structure is symmetric, consistent with the idea (17) that a dimeric GFL first binds two molecules of GFR␣, which then interacts with and dimerizes RET. Schlee et al. (18) have recently shown that ARTN first binds to a monomer of GFR␣3, followed by sequential recruitment of one RET molecule and then additional molecules of GFR␣3 and RET.
GDNF in complex with GFR␣1 can also signal through the neural cell adhesion molecule independent of RET (19) , and recent studies suggest that the GDNF 2 ⅐GFR␣1 2 complex can also act as an adhesin, mediating cell-cell interactions (20) . Furthermore, the N terminus of GDNF has been shown to bind heparin (21) . Understanding the structure of the GDNF 2 ⅐GFR␣1 2 complex may thus give insight into the various ways in which GDNF is involved in development and maintenance of neuronal and other cells.
We present here the crystal structure of the GDNF 2 ⅐GFR␣1 2 complex in the presence of a heparin mimic, sucrose octasulfate (SOS). Structural, mutagenesis, and biochemical studies have allowed us to understand the structural basis for ligand binding specificity. We have been able to identify the putative RETbinding site on GFR␣1 and to understand the structural basis for differential GFL signaling. Finally, our structure also suggests how GDNF 2 -GFR␣1 2 interactions might lead to cell-cell adhesion and RET-independent signaling.
MATERIALS AND METHODS

Expression and Purification of the GDNF 2 ⅐GFR␣1 2 Complex-
The numbering of the amino acid residues of rat GFR␣1 refers to SwissProt accession number Q62997. Primers included a His 6 tag, followed by a thrombin cleavage site for the truncated rat GFR␣1 construct, residues 145-425. We did not add His 6 tag to the mature human GDNF construct (GenBank TM ID AH003115, excluding the 77-residue preprosequence), numbered 1-134. We used human, not rat, GDNF, since in the 34 -134 region there are just six changes, the only nonconservative one being Met 3 Thr at residue 78. Both constructs were cloned into baculovirus vector pK503.9 (22), a pFastBac derivative (Invitrogen), which added a FLAG tag and an insect cell secretion signal sequence to the N terminus.
High titer GDNF and GFR␣1 baculovirus stocks grown in Sf9 cells were used at a 1:1 ratio to infect Tn5 cells for the coexpression of the protein complex. Cells were grown in serumfree HyQ-SFX medium (HyClone) supplemented with 50 g/ml gentamycin (Sigma) at ϩ27°C. Three days after co-infection, the supernatant was harvested by centrifugation to remove cellular material. Tangential flow concentration was used to concentrate the supernatant and to change the buffer to phosphate-buffered saline, pH 7.4. The GDNF 2 ⅐GFR␣1 2 complex was purified by adding Ni 2ϩ -resin (Ni 2ϩ -charged chelating Sepharose; GE Healthcare) to the concentrated supernatant in batch. After a 45-min incubation at ϩ4°C, the resin was washed with phosphate-buffered saline in the presence of 10 mM imidazole, and the complex was eluted with 500 mM imidazole in phosphate-buffered saline, pH 8.0. To remove the His tag, the buffer was adjusted to phosphate-buffered saline with spin concentrators, and the complex was incubated overnight at room temperature with 10 units of thrombin (GE Healthcare)/mg of the complex. Two millimolar SOS was added to the protein solution before gel filtration. Finally, the complex was purified by gel filtration on a Superdex 200 (GE Healthcare) column in HEPES-buffered (pH 7.5) 0.3 M NaCl and visualized on SDS-PAGE to check that a complex had formed (Fig. 1A) .
Site-directed Mutagenesis-The mutant clones of GFR␣1 were constructed using the QuikChange (Stratagene) site-directed mutagenesis protocol. The constructs were transformed into DH5␣ cells, and the transformed cells were selected on LB/ampicillin agar plates. The mutated plasmids were used for cloning into baculovirus. All clones were sequenced to ensure that no undesired mutations were introduced during PCR.
RET Activation and ELISA-RET phosphorylation assays were done in MG87RET cells, derived from the mouse NIH 3T3 cells, which are stably transfected with RET but do not express GFR␣1 (23) . MG87RET cells were starved for 4 h in serum-free Dulbecco's modified Eagle's medium at 37°C and subsequently stimulated for 60 min at 37°C by adding 1 g/ml soluble wildtype GFR␣1 D23C or mutant GFR␣1 D23C (Fig. 1B) with or without 100 ng/ml GDNF. After lysis with lysis buffer (Trisbuffered saline, 1% Triton X-100, 1% Nonidet P-40, 10% glycerol, 2 mM EDTA, 1 mM Na 3 VO 4, Complete Mini protease inhibitor from Roche Applied Science), the lysates were centrifuged in a tabletop centrifuge, at 10,000 rpm for 10 min to pellet the nuclei. The cleared lysates were applied to a 96-well plate (OptiPlate 96 F HB, Black; Wallac), which had been previously coated with 0.5 g/ml RET C-20 antibody (Santa Cruz Biotechnology) and blocked with 2% bovine serum albumin in Trisbuffered saline, and the plate was incubated at ϩ4°C for 1 h. Phosphorylated RET was detected using anti-phosphotyrosine antibodies (4G10; 1:1000 dilution; Upstate Biotechnology), anti-mouse horseradish peroxidase-conjugated antibodies (1:3000 dilution; DAKO A/S), and the enhanced chemiluminescence reaction (Femto ELISA ECL kit; Pierce). All washes between the incubations were done with the same washing buffer (Tris-buffered saline, 1% Triton X-100). Signal detection was done using a MicroBeta luminometer (PerkinElmer Life Sciences). The ELISA-based assay was more sensitive and had a much wider dynamic range than our previous Western blot assay (14) , because GFR␣1 was separately expressed in baculovirus/insect cells and was added as a soluble component.
MAPK Activity Assay-MG87RET cells were transfected with the MAPK activation detection system (Gal4-ELK plasmid and G4-Luc plasmid (6), a kind gift of Prof. J. Milbrandt) and plasmids expressing either rat GFR␣1 or human GFR␣3 (also from Prof. J. Milbrandt). Stably transfected cells were selected in the presence of 750 and 500 g of Geneticin/ml of growth medium, respectively. After selection, cells were cultivated in the culture medium (Dulbecco's modified Eagle's medium, 10% fetal bovine serum, normocin, 2 g/ml puromycin, 500 g/ml Geneticin, 15 mM HEPES, pH 7.2).
Six hours before the assay, cells were plated on 96-well plates at a cell density of 400,000 cells/ml. GDNF or ARTN was diluted in growth medium without selective antibiotics to a final concentration of 100 ng/ml and added to the cells for varying lengths of time. After incubation with the neurotrophic factors, the cells were washed once with culture medium and left for 24 h in the incubator to produce luciferase, followed by the addition of the cell lysis reagent (Promega) (20 l/well). Cells were incubated on a rotary shaker for 15 min and then subjected to one freeze-thaw cycle to ensure complete lysis. To measure luciferase activity, 5 l of lysate was added to 20 l of luciferase assay reagent (Promega) and counted on a MicroBeta luminometer (PerkinElmer Life Sciences).
Heparin Affinity Chromatography-The baculovirus expression system was used to produce full-length GFR␣1 as well as GFR␣1 D23C (14) . The recombinant GFR␣s had N-terminal FLAG-His 6 tags. Conditioned Sf9 culture supernatants (10 ml) were mixed with an equal volume of 40 mM sodium phosphate buffer (pH 7.0) and then applied to a 5-ml HiTrap Heparin column (GE Healthcare) at a flow rate of 1 ml/min. After a 10-ml wash step with 20 mM sodium phosphate buffer (pH 7.0, 150 mM NaCl), we applied a linear gradient of NaCl in the same buffer up to a final concentration of 2.0 M. One-milliliter fractions were collected and immunoblotted with anti-FLAG (M1; Sigma) antibodies as well as assayed for GDNF binding activity by a scintillation proximity assay. Scintillation proximity assay polyvinyltoluene beads precoated with anti-mouse antibodies (GE Healthcare) were used together with anti-FLAG antibodies and 125 I-labeled GDNF, as described (14) . Crystallography-Protein complex that had been purified by size exclusion chromatography (Fig. 1A) was deglycosylated with peptide:N-glycosidase F (New England Biolabs). The buffer was then changed to 10 mM HEPES (pH 7.5) supplemented with 150 mM NaCl, 0.01% (v/v) P8340 protease inhibitor mixture (Sigma), 0.001% NaN 3 , and the complex was crystallized at ϩ4°C using the Helsinki robot crystallization facility. The reservoir solution was 100 mM HEPES, pH 7.5, 10% polyethylene glycol 8000, 8% ethylene glycol, and the 200-nl drops were prepared by mixing 100 nl of the reservoir solution with 100 nl of the protein solution at 3 mg/ml. For data collection at Ϫ80°C, the crystal was frozen in liquid nitrogen with the well solution containing 20% (v/v) glycerol. A full data set to 2.35 Å resolution was collected using the ID14-EH2 beamline at ESRF (Grenoble, France) ( Table 1) . Diffraction data were processed using XDS (24) in space group C2 (Table 1) .
A single GFR␣1 co-receptor and one GDNF monomer together gave a Matthews coefficient (V M ) of 2.35 Å 2 /Da with 48% solvent content, suggesting that there was only a half of the quaternary complex per asymmetric unit. The other half of the complex is formed by the crystallographic 2-fold symmetry about the unique axis. We solved the structure by molecular replacement using the human GFR␣3 domains 2 and 3 from the ARTN 2 ⅐GFR␣3 2 complex structure (Protein Data Bank code 2GH0 (13)) and rat GDNF (Protein Data Bank code 1AGQ (25)) as search models with Phaser (26). The initial R-factor after molecular replacement and one round of rigid body refinement was 48.5 (R free 47%).
After 10 cycles of automated model building using ArpWarp (27) , 69% of the residues had been built, and Refmac5 (28) refinement resulted in an initial R work of 20% (R free ϭ 31%). Iterative model building and refinement using Coot (29) and Refmac5 gave a final model with R work 18.4% (R free ϭ 23.7%). Individual isotropic B factors were refined using restrained refinement. Water molecules were added with Coot (29) to peaks above 3.5 in the F o Ϫ F c difference electron density map if they had suitable hydrogen bonding geometry and eliminated if they refined to a B-factor of greater than 70. The electron density quality was good throughout both the GDNF and GFR␣1 structures (supplemental Fig. 1A ) and more than 90% of residues were in the most favored regions of the Ramachandran plot (30) ( Table 1 ). The first five residues of GFR␣1 were disordered. The flexible N-terminal region of GDNF and the GFR␣1 C-terminal extension (76 residues) were not visible due to proteolytic cleavage, as shown by SDS-PAGE of the crystals (data not shown). The ligand library for SOS and N-acetylglucosamine was generated with PRODRG (31) . We validated the model using tools in Coot (29) and PROCHECK (30) . Structural alignments were done using Coot (29) and PyMol (32) , and sequence alignments were done using ClustalW (33) .
RESULTS
Biochemical and Structural Characterization of GDNF 2 ⅐ GFR␣1 2 Complex-We co-expressed GFR␣1 domain 2-3-C (GFR␣1 D23C) with GDNF in Tn5 insect cells and purified the GDNF 2 ⅐GFR␣1 2 complex in two steps: Ni 2ϩ -Sepharose affinity purification in batch followed by size exclusion chromatography. SDS-PAGE showed that fraction 6 from the gel filtration column, which ran at about 100 kDa, contained two proteins, one of molecular mass 38 kDa (GFR␣1 D23C) and the other of molecular mass 22 kDa (GDNF) (Fig. 1A) . The crystal structure was solved by molecular replacement and refined using standard techniques (see "Materials and Methods") to R work 18.4% (R free 23.7%), and the final model contained residues 150 -349 of GFR␣1 and residues 34 -134 of GDNF (Table 1) .
Overview of the GDNF 2 ⅐GFR␣1 2 Complex and the Ligand Coreceptor Interface-In the GDNF 2 ⅐GFR␣1 2 complex, each GDNF monomer of the cysteine-linked homodimer, with two ␤-stranded finger loops and a helical heel (supplemental Fig.  1B ), binds GFR␣1 on its finger domain ( Fig. 2A) . As expected from sequence analysis and the ARTN 2 ⅐GFR␣3 2 structure (13) (Fig. 2B) , GFR␣1 D2 and D3 are both "triangular helix spiral" domains (14) (Fig. 2A) . The two domains of GFR␣1 pack so that D3 stabilizes D2, which in turn binds GDNF ( Fig. 2A) .
One N-acetylglucosamine molecule is covalently linked to GDNF N49, and an SOS molecule binds to domain 2 in GFR␣1 ( Fig. 2A) . Through a crystal contact, SOS also binds to the N terminus of a symmetry-related GDNF.
At the GDNF⅐GFR␣1 interface, the GDNF fingertips interact with the GFR␣1 D2 through the center of the triangular helix spiral formed by ␣-helices ␣1, ␣2, and ␣5 (supplemental Fig.  1B) . The GDNF⅐GFR␣1 interface is composed of 14 contact residues from GDNF and 18 from GFR␣1 D2 (Table 2) , burying ϳ950 Å 2 as calculated with POPScomp (34) . As in the ARTN⅐GFR␣3 complex (13) , the center of the interface is the Arg-171 GFR␣1 -Glu-61 GDNF -Arg-224 GFR␣1 ion triple (Fig. 2C ). Asn-162 GFR␣1 is very important (see below) in stabilizing the ion triple. The amide CϭO positions the Arg-171 GFR␣1 guanidine group, whereas the amide -NH 2 positions Glu-61 GDNF by forming three hydrogen bonds, to the Glu-62 GDNF and Ser-112 GDNF backbone carbonyls and to the carboxylate side chain of Glu-61 GDNF (Fig. 2C) Heparin Binding Studies-The heparin mimic sucrose octasulfate (SOS) binds to and co-purifies with the GDNF 2 ⅐GFR␣1 2 complex over the gel filtration column. The negatively charged sulfate groups bind to , and Lys-202 on GFR␣1 D2 and to Asn-253, Tyr-254, and Arg-259 in the ␣6-␣7 turn of GFR␣1 D3 (Fig. 3A) . SOS also mediates a crystal contact with GDNF in the neighboring complex. It binds Arg-35, Lys-37, and Arg-39 in the GDNF heel region (Fig. 3B) , consistent with recent biochemical studies (21) .
The heparin-binding properties of the full-length GFR␣1 and GFR␣1 D23C were also tested with a heparin column (Fig.  3C) . The full-length GFR␣1 eluted only at very high (Ͼ1 M) NaCl concentration, indicating strong binding. GFR␣1 D23C eluted at about half of the concentration, suggesting reduced but still specific binding. These results and the presence of SOS in the crystal structure are consistent with earlier suggestions that the Arg-190 to Lys-202-positive patch in GFR␣1 D2 might bind heparan sulfate (14, 35) . This could explain why exogenous heparin can inhibit RET signaling (35) if RET also binds to the same region.
Mutagenesis and Binding StudiesWe made a series of mutants, which fell into three categories: mutants in the GDNF⅐GFR␣1 interface (K159A, N162A, K168A, and I175G); mutants in the "SOSbinding" region (R190A/R197A, K194A, Q198A/K202A, and R257A/ R259A); and "RET-binding" residues (13) (D164A, R257A/R259A, and E323A/D324A) (supplemental Fig. 1C ). The first category probes specific details of the GDNF⅐GFR␣1 interface to try to gain a fuller understanding of what aspects of the interface are important for specificity; the second category tests if the SOS-binding region is important for RET and/or heparin binding; and the third examines the region predicted by Wang et al. (13) to bind RET (supplemental Fig. 1C) . In addition, we tested two mutations outside these regions: R217E, which had appeared to show some allosteric effects (14) , and R240A, on the opposite side of the GFR␣1 to the SOS-binding surface. We used MG87RET cells (expressing RET) and detected the RET tyrosine phosphorylation by ELISA.
The mutations N162A and I175G in the key buttressing interactions in the center of the GDNF⅐GFR␣1 interface caused the largest changes (more than 95% reduction with respect to wild type) in RET phosphorylation (Table 3) . Mutations to peripheral residues in the GDNF-binding interface, such as K159A and K168A, reduced phosphorylation much less (60 and 35% as active as wild type (Table 3 and Fig. 1B) ). The effect of the D164A mutant was also very small, suggesting that Asp-164 is not important. The changes in IC 50 as measured by scintillation proximity assay with 125 I-labeled GDNF were consistent with these results. However, most significant is our direct experimental evidence for the probable RET-binding interface. Arg-190, Lys-194, Arg-197, Gln-198, Lys-202, Arg-257, Arg-259, Glu-323, and Asp-324 are all on the surface of GFR␣1 (Fig. 3D) , not in the GDNF⅐GFR␣1 interface, yet mutation reduces RET phosphorylation by a factor of 3 or more (Table 3 and Fig. 1B) . Thus, these residues interact with RET. The effect of the E323A/ D324A and R257A/R259A mutants is consistent with earlier predictions (13) . The slightly greater effect of the R190A/ R197A, K194A, and Q198A/K202A mutants (Table 3 and Fig.  1B ) suggest that the RET-binding and heparin-binding interfaces (Fig. 3, A and D) may overlap, as mentioned above. Binding studies were consistent with these results. 5 Structural and Signaling Differences between GDNF 2 ⅐GFR␣1 2 and ARTN 2 ⅐GFR␣3 2 Complexes-The GDNF 2 ⅐GFR␣1 2 and ARTN 2 ⅐GFR␣3 2 (Protein Data Bank code 2GH0 (13)) structures are similar in three respects: the GFL fingertips bind their respective co-receptor through the center of the triangular helix spiral (Fig. 4A) ; both contain the same Arg-171
GFR␣1 ion triple (Arg-179-Glu-143-Arg-233 in ARTN⅐GFR␣3); and the GFR␣1 and GFR␣3 structures are highly similar (root mean square deviation of 0.89 Å for 166 C␣ atoms). Despite the above, the complexes differ in three important ways.
First, the approach of the ligand fingers at the ligand-coreceptor interface is different (Fig. 4A) . With respect to GDNF, the ARTN fingers twist about their longitudinal axis and turn around a vertical axis (Fig. 4A) emanating out of the GFR␣ triangular helix spiral by about 20°.
Second, there are differences in the core region of the ligandco-receptor binding interface. As mentioned above, GFR␣1 N162 buttresses the Arg-Glu-Arg ion triple (Fig. 2C) , and the GFR␣1 N162A mutant shows no stimulation of RET phosphorylation (Table 3 ). The equivalent GFR␣3 Thr-170 makes no interactions at all. The changes in hydrophobic packing by the GFR␣s around GDNF Tyr-120 versus ARTN Trp-205 are equally as important. As can be seen (Fig. 4B) , the GFR␣3 pocket is wider and not as deep, consistent with it binding Trp, not Tyr. The difference in the shape of the hydrophobic pocket is due to the Ile-175 GFR␣1 3 Gly GFR␣3 and Val-230 GFR␣1 3 Ala GFR␣3 changes. These changes are important in determining the specificity. Such changes would lead to GDNF binding poorly to GFR␣3 and vice versa (Fig. 4B) . Consistent with this, (13)), viewed at the same scale and in the same schematic diagram and orientation as GDNF 2 ⅐GFR␣1 2 in Fig. 2A . The ARTN monomers are pea green and light yellow, the GFR␣3 D2s are blue, and the GFR␣3 D3s are red. A and B emphasize the difference in bend angle between the two complexes (see "Results" for details). Since the scale (not shown) is the same, it is clear that the GDNF 2 ⅐GFR␣1 2 heterotetramer is the more compact of the two complexes. C, close-up view of the GDNF⅐GFR␣1 interface in stereo, showing the interface residues as sticks, color-coded by atoms (red, oxygen; blue, nitrogen; cyan, carbon (GFR␣1); salmon, carbon (GDNF)). GFR␣1 is shown in a blue loop ribbon, and GDNF is shown in a salmon loop ribbon. The residues mutated in this study are labeled red. This figure and Figs. 3-5 were made using PyMol (32). 
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the Ile-175 GFR␣1 3 Gly mutation alone reduces GDNF stimulation of GFR␣1-RET more than 20-fold (Table 3) .
Third, the ARTN and GDNF monomer finger loop regions, relative to the aligned helical heel, are inclined by about 20°in comparison with each other (Fig. 4C) . Consequently, the dimer bend angle difference between bound GDNF 2 and ARTN 2 is 44°, because the GDNF homodimer is bent and the ARTN homodimer is planar. The large change in bend angle between GDNF 2 and ARTN 2 makes it impossible to superimpose the structures globally. The root mean square deviation/C␣ between GDNF 2 and ARTN 2 homodimers is over 5 Å. Unbound GDNF (25) and ARTN (36) also have a similar difference in their bend angle; the difference is thus not due to co-receptor binding. In addition, another (GDNF⅐GFR␣1) 2 crystal structure grown in the absence of SOS with therefore We searched for residues in GFR␣1 that were within 4 Å of residues in GDNF. different crystal packing, 6 has a similar bend angle to the (GDNF⅐GFR␣1) 2 complex described here.
GDNF GFR␣1
These differences mean that the quaternary structures of the two complexes are dissimilar (Fig. 2, A and B) . This, we believe, explains how GFLs cause differential signaling through RET, although RET phosphorylation is unchanged (37) . The different bend angles could change the presentation of the RET tyrosine kinase domains on the inside of the cell and thus alter the surfaces that are available for adaptor proteins to dock (see "Discussion").
We therefore decided to reinvestigate whether there were signaling differences between GDNF and ARTN, although earlier reports showed no difference in RET phosphorylation nor in how fast phosphorylation occurs (37) . Our results show that GDNF activates the MAPK pathway faster than ARTN, as measured by our luciferase readout system (Fig. 4D) .
SOS as a Model for Heparin-Previous studies showed that 2-O-sulfation was important in binding of heparin to GDNF (38) and in biological assays of function, such as ureteric bud branching in developing kidneys (39) . Davies et al. (39) also showed that the minimum length of heparin capable of inhibition was about 12 saccharides long.
Our work may help explain why. The distances between nearest neighbor 2-O-sulfates in heparin are about 9 -12 Å, similar to the 10.4-Å spacing between the SOS C3 and C14 sulfates that bind GFR␣1 (Fig. 3A) . It was therefore easy to model a heparin pentasaccharide into the SOS-binding region with the 2-O-sulfates in a similar orientation to those of SOS (Fig. 5) . Since mutations in this region affect RET phosphorylation (Table 3) , exogenous heparin could prevent RET binding to the GDNF 2 ⅐GFR␣1 2 complex and thus inhibit RET phosphorylation and signaling. Such inhibition would depend on both length and 2-O-sulfation, as has been observed (21, 39) .
DISCUSSION
A Putative RET Binding Surface-Wang and co-workers (13) proposed that a conserved charged surface on GFR␣3, including Asp-164, Lys-202, Arg-257, Arg-259, Glu-323, and Asp-324 (GFR␣1 numbering), bound RET. However, they showed no experiments to demonstrate that this was so. Our mutagenesis and RET phosphorylation ELISA assays, therefore, are the first experimental demonstration of a putative RET-binding interface on GFR␣1 (Fig. 3D) . Of the proposed residues, Asp-164 is not in the RET interface (Table 3) , but the other ones are (Fig.  3D ). In addition, we have also identified other positively charged surface-exposed residues near Lys-202 as being in the RET interface: (Fig. 3D) . The RET interface thus extends the full length of the exposed surface of both domains 2 and 3 (Fig. 3D) . The positively charged region on domain 2 could interact with the negatively charged RET cysteine-rich domain (residues 516 -636), consistent with cross-linking studies (40) . Furthermore, both this region and the RET cysteine-rich domain are close to the membrane. The other part of the putative RET interface, at the tip of D3 near Glu-323/Asp-324 and thus farther away from the cell surface (13) , may interact with the RET cadherin-like domains (41) .
RET Activation Is a Result of Proximity-The structure of the RET tyrosine kinase domain does not change upon phosphorylation, and the nonphosphorylated kinase domain is active (42) . Lack of phosphorylation of the "A-loop" structure (43) interferes with neither ATP nor substrate binding (42) , unlike in most receptor tyrosine kinases (43) . The RET tyrosine kinase thus appears to be always active, and all GFLs appear to induce the same level of RET phosphorylation (37) . Nonetheless, a recent report suggested that NRTN and GDNF activate MAPK and phospholipase C-␥ differently (44) . In addition, our MAPK luciferase assay indicates a higher level signaling through RET by GDNF than ARTN (Fig. 4D) .
Differences in the binding interface and in the GFL bend angle (Fig. 4 , A and C) may explain the differential activation. They change the quaternary arrangement of the rigid GFR␣s in the heterotetramer complex (Fig. 2, A and B) . For instance, the distance between the Glu-323 C␣s on GFR␣1 in GDNF 2 ⅐GFR␣1 2 is 115 Å, whereas the equivalent distance in ARTN 2 ⅐GFR␣3 2 is 135 Å. Since the RET interaction interface seems to be conserved in GFR␣s, the arrangement of the extracellular RET domains must change. This might affect the positioning of the RETs with respect to each other on the inside of the membrane and thus which tyrosines are available to bind downstream effectors (45) . Such changes could lead to different downstream signaling complexes and the variable signaling observed (44) (Fig. 4D) . It is, of course, possible that the GFL⅐GFR␣ complexes all adopt the same conformation upon binding RET, but this seems unlikely, since all of the ARTN structures solved so far have been essentially flat (13, 36) , whereas all of the GDNF structures have been bent (25) (Fig.  4C) . The variable presentation suggested above might also explain why the GFR␣ homologue Gas1, which does not require a GFL to signal through RET, activates targets different from those activated by GDNF 2 ⅐GFR␣1 2 (46). 6 Parkash, unpublished results. The Role of Heparan Sulfate in GDNF Signaling-Alfano et al. (21) showed that heparin binds chiefly to the N-terminal 40 residues of GDNF, in particular residues 24 -39 (supplemental Fig. 1D ). 7 Although our GDNF structure is truncated at residue 34, it nonetheless contains part of this proposed heparin-binding site, and the heparin mimic SOS binds GDNF. The GDNF residues that interact are Arg-35, Lys-37, and Arg-39 ( Fig. 3B) and possibly Lys-84 in the GDNF heel region.
Our structure thus supports the biochemical data, and it further explains how heparin can inhibit RET signaling even after the "heparin-binding sequence" in GDNF (residues 24 -39) is removed (21) . We believe that heparin inhibits RET signaling by binding to the Arg-190 to Lys-202 patch on helix ␣3 in GFR␣1 D2 (Fig. 3A) . The biochemically identified heparin interactions with the N terminus of GDNF and with GFR␣1 D1 should thus have different biological roles. One possibility is discussed below.
In Trans Signaling and Cell Adhesion-Very recent work has shown that, in the absence of RET, the GDNF 2 ⅐GFR␣1 2 complex causes signaling at the synapse during development. Ledda et al. (20) suggested that GDNF 2 ⅐GFR␣1 2 could act as an adhesin and play an active role in synapse induction. The structural arrangement in the crystal suggests that this may be due to heparin-linked oligomerization of the GDNF 2 ⅐GFR␣1 2 tetramers between cells. There are three heparin-binding regions: the N terminus (residues 24 -39) and the "heel" of GDNF (21, 36) (Fig. 3B ), GFR␣1 D1 (Fig. 3C) , and the GFR␣1 D2 Arg-190 to Lys-202 region (Fig. 3A) .
In our crystal structure, SOS links a GDNF 2 ⅐GFR␣1 2 tetramer to its crystallographic neighbor by interacting on one side with the N terminus and heel region of GDNF and on the other side with GFR␣1 D2 helix ␣3 (Fig. 3B) . SOS thus mediates "dimer-of-heterotetramer" formation in the crystal, and we believe that heparin might also cross-link GDNF 2 ⅐GFR␣1 2 tetramers. Such cross-linking could extend from cell to cell.
Although such a model is highly speculative, it is consistent with the observed GDNF 2 ⅐GFR␣1 2 -induced cell adhesion and synapse formation (20) . Finally, our model also suggests that this should occur for GDNF 2 ⅐GFR␣1 2 and NRTN 2 ⅐GFR␣2 2 but not for ARTN 2 ⅐GFR␣3 2 and PSPN 2 ⅐GFR␣4 2 . GFR␣3 has three changes in the domain 2 heparin-binding patch (R190H, K194A, and Q198S (GFR␣1 numbering) (supplemental Fig. 1D) ), whereas PSPN lacks the N-terminal heparin-binding region and does not bind heparin (47) . Without heparin binding, the multimerization required for GFL⅐heparin⅐GFR␣-mediated cell adhesion would not occur.
Conclusion-Our studies of the GDNF 2 ⅐GFR␣1 2 complex suggest how ligand binding, specificity, and affinity are related in this important neurotrophic factor-receptor system. They A, superposition of the GFL⅐GFR␣ monomers to show the difference in approach between GDNF and ARTN viewed from above looking into the triangular helix spiral. The GFR␣s were superimposed. Sand, GFR␣1; slate, GFR␣3; salmon, GDNF; pea green, ARTN. This view emphasizes the difference in rotation between GDNF and ARTN finger loops above the triangle of helices. B, close-up of the "cross-talk" ligand-co-receptor complex interfaces in stereo. In the top panel, the GFR␣3 in a partially transparent surface representation is positioned below GDNF, and GFR␣1 is shown similarly below ARTN in the bottom panel. The GFR␣1, GFR␣3, GDNF, and ARTN are in same color and alignment as in A. The key differences between GFR␣1 and GFR␣3 are shown in orange balls, and the two arginines of the ion triple are in balls with carbon (sand), oxygen (red), and nitrogen (blue). The key GDNF (Glu-61, Leu-114, and Tyr-120) and ARTN (Glu-143, Met-199, and Trp-205) residues are shown as ball-and-stick models. C, the ligand bend angle difference. The conserved ligand monomer heel structures were aligned to show the relative inclination of the finger loops. Two conformations of GDNF (25) interface. GFRα1 residues N162, R171, Y174, R224 and GDNF residues E61 and N49 are shown in stick representation.
(B) GDNF-GFRα1 in the asymmetric unit. Helices are shown as cylinders, β-strands as arrows. Both GFRα1 D23 and GDNF are "rainbow"-coloured from blue at the N-terminus to red at the C-terminus.
The helices of GFRα1 D23 are labelled, as are the GDNF finger loops and helical heel.
(C) GFRα1 D23 mutated residues. GFRα1 D23 is shown in the same colour scheme as in figure 2A .
The GFRα1 D23 helices are represented as spirals. C α s for various mutations studied in this work are displayed here as spheres. These C α spheres for SOS binding residues are in blue for conserved (R197, K202, R257, R259) and orange for non-conserved (R190, K194, Q198, N253, Y254); and the GDNF interface residues are in green for core (N162, I175) and yellow for peripheral (K159, K168); and other mutated C α s in sand. Disulphide bridges are shown in light blue sticks.
(D) Alignments of key regions of the rat GFRα and GFL sequences along with human GFRα1 and human GDNF, respectively. Key conserved residues have a red background for the GDNF-GFRα1 interface and blue for GFRα1-SOS interface. Other residues at the SOS binding site of GFRα1 have an orange background. The core hydrophobic residues at the GDNF-GFRα1 interface have a green background and the peripheral contact residues in the GDNF-GFRα1 interface have a yellow background. Other potential RET binding residues have a brown background.
